 HOUSTON, June 01, 2022 GLOBE NEWSWIRE -- Alaunos Therapeutics, Inc. Alaunos or the Company Nasdaq: TCRT, a clinical-stage oncology-focused cell therapy company today announced that Kevin S. Boyle Sr., Chief Executive Officer and Drew Deniger, Ph.D., Vice President, Research Development will present at the upcoming Jefferies Healthcare Conference being held on June 8-10, 2022, in New York, NY. 